Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gastroenterología y hepatología 2019-06, Vol.42 (6), p.387-388
Hauptverfasser:	Ferrer Bradley, Isabel, Maroto Arce, Nuria, Mora Escrig, María, Hinojosa Del Val, Joaquín
Format:	Artikel
Sprache:	eng ; spa
Schlagworte:	Adalimumab - adverse effects Adalimumab - therapeutic use Adrenal Cortex Hormones - adverse effects Adrenal Cortex Hormones - therapeutic use Adult Anti-Inflammatory Agents - adverse effects Anti-Inflammatory Agents - therapeutic use Antifungal Agents - therapeutic use Cilastatin - therapeutic use Crohn Disease - complications Crohn Disease - drug therapy Diagnosis, Differential Disease Susceptibility Humans Imipenem - therapeutic use Immunocompromised Host Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Male Opportunistic Infections - diagnosis Opportunistic Infections - drug therapy Opportunistic Infections - etiology Pulmonary Aspergillosis - diagnosis Pulmonary Aspergillosis - drug therapy Pulmonary Aspergillosis - etiology Tomography, X-Ray Computed Tuberculosis, Pulmonary - diagnosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!